TSWM
TEVA icon

Tyler-Stone Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Tyler-Stone Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72
Closed -$1.17K – 879
2024
Q2 		$1.17K Hold
72
– – ﹤0.01% 898
2024
Q1 		$1.02K Hold
72
– – ﹤0.01% 896
2023
Q4 		$752 Hold
72
– – ﹤0.01% 883
2023
Q3 		$1K Hold
72
– – ﹤0.01% 889
2023
Q2 		$1K Buy
+72
New +$584 ﹤0.01% 871
2022
Q4 		$2K Hold
272
– – ﹤0.01% 770
2022
Q3 		$2K Hold
272
– – ﹤0.01% 767
2022
Q2 		$2K Hold
272
– – ﹤0.01% 777
2022
Q1 		$3K Hold
272
– – ﹤0.01% 734
2021
Q4 		$2K Buy
+272
New +$2.46K ﹤0.01% 818

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Tyler-Stone Wealth Management's TEVA Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 72 shares — an estimated $1.17K sold.

Tyler-Stone Wealth Management first reported a position in TEVA in Q4 2021 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 72 Teva Pharmaceuticals shares in Q3 2024, an estimated $1.17K.
  • Tyler-Stone Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Teva Pharmaceuticals position peaked at $3K in Q1 2022.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.